Wei X, Yang J, Adair SJ, Ozturk H, et al. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Proc Natl Acad Sci U S A 2020 Oct 23. pii: 2009899117.
PMID: 33097661